{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:54:39Z","timestamp":1790736879573,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21ES034801"],"award-info":[{"award-number":["R21ES034801"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02340-6","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:27:28Z","timestamp":1783427248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum perfluoroalkyl substances (PFASs) concentrations and associations with mammographic density in postmenopausal women"],"prefix":"10.1186","volume":"28","author":[{"given":"Sabiha","family":"Nasrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Oulhote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hadro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-981X","authenticated-orcid":false,"given":"Katherine W.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2340_CR1","doi-asserted-by":"publisher","first-page":"105048","DOI":"10.1016\/j.envint.2019.105048","volume":"131","author":"AM Calafat","year":"2019","unstructured":"Calafat AM, et al. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013\u20132014 National Health and Nutrition Examination Survey. Environ Int. 2019;131:105048.","journal-title":"Environ Int"},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","volume":"29","author":"EM Sunderland","year":"2019","unstructured":"Sunderland EM, et al. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 2019;29:131\u201347.","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2340_CR3","volume-title":"Guidance on PFAS Exposure, Testing, and Clinical Follow-Up","author":"M Health","year":"2022","unstructured":"Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice, Health M. Board on Environmental Studies and Toxicology; Committee on the Guidance on PFAS Testing and Health Outcomes. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington (DC): National Academies Press (US); 2022."},{"key":"2340_CR4","unstructured":"IARC. Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS)."},{"key":"2340_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/aje\/kwae010","volume":"193","author":"C-J Chang","year":"2024","unstructured":"Chang C-J, et al. Exposure to per- and polyfluoroalkyl substances and breast cancer risk: a systematic review and meta-analysis of epidemiologic studies. Am J Epidemiol. 2024;193:1182\u201396.","journal-title":"Am J Epidemiol"},{"key":"2340_CR6","doi-asserted-by":"publisher","first-page":"dju078","DOI":"10.1093\/jnci\/dju078","volume":"106","author":"A Pettersson","year":"2014","unstructured":"Pettersson A, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106:dju078.","journal-title":"J Natl Cancer Inst"},{"key":"2340_CR7","first-page":"163","volume":"154","author":"NF Boyd","year":"2001","unstructured":"Boyd NF, et al. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001;154:163\u20139.","journal-title":"IARC Sci Publ"},{"key":"2340_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0041-008X(92)90116-A","volume":"113","author":"JC Cook","year":"1992","unstructured":"Cook JC, Murray SM, Frame SR, Hurtt ME. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol Appl Pharmacol. 1992;113:209\u201317.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2340_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/taap.1995.1164","volume":"134","author":"LB Biegel","year":"1995","unstructured":"Biegel LB, Liu RC, Hurtt ME, Cook JC. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol. 1995;134:18\u201325.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2340_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.reprotox.2008.10.003","volume":"27","author":"C Yang","year":"2009","unstructured":"Yang C, Tan YS, Harkema JR, Haslam SZ. Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl\/6 and Balb\/c mouse strains. Reprod Toxicol Elmsford N. 2009;27:299\u2013306.","journal-title":"Reprod Toxicol Elmsford N"},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/toxsci\/kfq030","volume":"115","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Tan YS, Haslam SZ, Yang C. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL\/6 mice. Toxicol Sci Off J Soc Toxicol. 2010;115:214\u201324.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"2340_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jsbmb.2009.09.010","volume":"118","author":"B Zhao","year":"2010","unstructured":"Zhao B, Chu Y, Hardy DO, Li X, Ge R-S. Inhibition of 3beta- and 17beta-hydroxysteroid dehydrogenase activities in rat Leydig cells by perfluorooctane acid. J Steroid Biochem Mol Biol. 2010;118:13\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/toxsci\/kfr267","volume":"125","author":"AD Benninghoff","year":"2012","unstructured":"Benninghoff AD, et al. Promotion of hepatocarcinogenesis by perfluoroalkyl acids in rainbow trout. Toxicol Sci Off J Soc Toxicol. 2012;125:69\u201378.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"2340_CR14","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1200\/JCO.2010.33.7964","volume":"29","author":"NF Boyd","year":"2011","unstructured":"Boyd NF, et al. Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:2985\u201392.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"E606","DOI":"10.3390\/ijerph17020606","volume":"17","author":"E Lee","year":"2020","unstructured":"Lee E, et al. Serum levels of commonly detected persistent organic pollutants and per- and polyfluoroalkyl substances (PFASs) and mammographic density in postmenopausal women. Int J Environ Res Public Health. 2020;17:E606.","journal-title":"Int J Environ Res Public Health"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"97008","DOI":"10.1289\/EHP14065","volume":"132","author":"YS Ning","year":"2024","unstructured":"Ning YS, et al. PFAS levels, early life factors, and mammographic breast density in premenopausal women. Environ Health Perspect. 2024;132:97008.","journal-title":"Environ Health Perspect"},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1158\/1940-6207.CAPR-11-0234","volume":"5","author":"ME Sherman","year":"2012","unstructured":"Sherman ME, et al. The Susan G. Komen for the cure tissue bank at the iu simon cancer center: a unique resource for defining the molecular histology of the breast. Cancer Prev Res (Phila Pa. 2012;5:528\u201335.","journal-title":"Cancer Prev Res (Phila Pa"},{"key":"2340_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/oemed-2017-104651","volume":"75","author":"Y Li","year":"2018","unstructured":"Li Y, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75:46\u201351.","journal-title":"Occup Environ Med"},{"key":"2340_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","volume":"59","author":"F P\u00e9rez","year":"2013","unstructured":"P\u00e9rez F, et al. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 2013;59:354\u201362.","journal-title":"Environ Int"},{"key":"2340_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acs.est.3c06499","volume":"58","author":"F Nielsen","year":"2024","unstructured":"Nielsen F, Fischer FC, Leth PM, Grandjean P. Occurrence of major perfluorinated alkylate substances in human blood and target organs. Environ Sci Technol. 2024;58:143\u20139.","journal-title":"Environ Sci Technol"},{"key":"2340_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13058-015-0626-8","volume":"17","author":"BM Keller","year":"2015","unstructured":"Keller BM, Chen J, Daye D, Conant EF, Kontos D. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography. Breast Cancer Res BCR. 2015;17:117.","journal-title":"Breast Cancer Res BCR"},{"key":"2340_CR22","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1118\/1.4736530","volume":"39","author":"BM Keller","year":"2012","unstructured":"Keller BM, et al. Estimation of breast percent density in raw and processed full field digital mammography images via adaptive fuzzy c-means clustering and support vector machine segmentation. Med Phys. 2012;39:4903\u201317.","journal-title":"Med Phys"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02772248.2020.1763997","volume":"102","author":"W Qi","year":"2020","unstructured":"Qi W, Clark JM, Timme-Laragy AR, Park Y. Per- and polyfluoroalkyl substances and obesity, Type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings. Toxicol Environ Chem. 2020;102:1\u201336.","journal-title":"Toxicol Environ Chem"},{"key":"2340_CR24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ijc.23996","volume":"124","author":"KW Reeves","year":"2009","unstructured":"Reeves KW, et al. Longitudinal association of anthropometry with mammographic breast density in the Study of Women\u2019s Health Across the Nation. Int J Cancer. 2009;124:1169\u201377.","journal-title":"Int J Cancer"},{"key":"2340_CR25","first-page":"1724","volume":"24","author":"V Hart","year":"2015","unstructured":"Hart V, et al. The effect of change in body mass index on volumetric measures of mammographic density. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2015;24:1724\u201330.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"2340_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.reprotox.2016.07.010","volume":"68","author":"CAG Timmermann","year":"2017","unstructured":"Timmermann CAG, et al. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances. Reprod Toxicol Elmsford N. 2017;68:164\u201370.","journal-title":"Reprod Toxicol Elmsford N"},{"key":"2340_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.envres.2016.04.034","volume":"149","author":"ME Romano","year":"2016","unstructured":"Romano ME, et al. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environ Res. 2016;149:239\u201346.","journal-title":"Environ Res"},{"key":"2340_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13058-025-02103-9","volume":"27","author":"KW Reeves","year":"2025","unstructured":"Reeves KW, Oulhote Y, Grandjean P, Nielsen F. Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast. Breast Cancer Res BCR. 2025;27:148.","journal-title":"Breast Cancer Res BCR"},{"key":"2340_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-016-3908-7","volume":"159","author":"JD Figueroa","year":"2016","unstructured":"Figueroa JD, et al. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study. Breast Cancer Res Treat. 2016;159:163\u201372.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02340-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:55:37Z","timestamp":1790733337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02340-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02340-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All Komen Tissue Bank participants provided written informed consent at the time of donation. All procedures involving human participants were conducted in accordance with the Declaration of Helsinki. Human subjects approval for the Komen Tissue Bank was provided by the Institutional Review Board at Indiana University. The present research utilized fully deidentified data and previously collected biospecimens and thus was determined to not qualify as human subjects research by the Institutional Review Board at the University of Massachusetts Amherst.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PG has served as a health expert for PFAS-exposed populations in legal cases. KR, YO, SN, JH, AL and FN declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"164"}}